Improving self-management for people with inflammatory bowel disease
Official title: A Comprehensive Self-Management Intervention for individuals with Inflammatory Bowel Disease
Funded at University of Washington · NIH-10813882 · Data updated 2026-11-12
This study is testing a new program to help people with inflammatory bowel disease, like Crohn's and ulcerative colitis, better manage their symptoms and improve their daily lives, and we’d love for you to join us to see how well it works compared to regular care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project start | April 12, 2022 |
| Project end | September 30, 2025 |
| Funding year | 2024 |
| Award (this year) | $143,378 |
| NIH project number | 5K23NR020044-03 |
| Project ID | NIH-10813882 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are individuals diagnosed with inflammatory bowel disease, including Crohn's disease and ulcerative colitis.
✕Less likely to help
Patients without a diagnosis of inflammatory bowel disease or those who are not experiencing significant symptoms may not benefit from this research.
What this research studies
This research focuses on developing a Comprehensive Self-Management Intervention (CSM-IBD) specifically for individuals with inflammatory bowel disease (IBD), which includes conditions like Crohn's disease and ulcerative colitis. The intervention aims to help patients manage their symptoms, such as abdominal pain, fatigue, and anxiety, by adapting a previously successful program used for irritable bowel syndrome. Participants will be involved in a randomized controlled trial to assess the feasibility and effectiveness of this intervention compared to usual care, with a focus on improving quality of life and daily symptom management. The study will also explore how various socioecological factors influence symptoms in this population.
Why it matters
Potential benefit: If successful, this research could significantly enhance the quality of life for patients with inflammatory bowel disease by providing effective self-management strategies.
How similar studies have gone: Previous research has shown success with similar self-management interventions in other gastrointestinal conditions, indicating potential for effectiveness in this new population.
Where this research is happening
-
University of Washington
Seattle, United States Active
Researchers
- Principal investigator: Kamp, Kendra Joy — University of Washington
- Study coordinator: Kamp, Kendra Joy
Related research
Other NIH-funded projects on the same topics.
-
Improving health management for patients with inflammatory bowel disease
This study is creating a helpful online tool for people with inflammatory bowel disease (IBD) to learn how to manage their symptoms better and improve their daily lives.
-
Michigan Diabetes Project: A Peer-Led Self-Management Program for Adults with Type 2 Diabetes
A peer-led self-management program for adults with type 2 diabetes is being tested to see if it improves blood sugar control and daily diabetes care.
-
Economic evaluation of MEW Network epilepsy self-management programs for broad adoption
This project tests how cost-effective two epilepsy self-management programs (UPLIFT and PACES) are when used in real-world healthcare and community settings, to help people with epilepsy live better.
-
Economic analysis of the MEW self-management program for epilepsy (MINDSET) in real-world settings
This grant studies how a proven epilepsy self-management program can be implemented in communities and clinics, and how its costs and benefits stack up.
-
EDGE: A personalized, digital diabetes support program with real-time glucose feedback
A digital program for adults with type 2 diabetes uses real-time glucose data, coaching, and engaging features to help them manage their condition better.
-
Self-management Apps with AI to Help Emerging Adults Reduce Substance Use and Costs
A new AI-powered self-management program for 18- to 25-year-olds with substance use issues aims to reduce use, overdoses, and costs by delivering scalable, smartphone-based support.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.